Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,122 | 715 | 99.2% |
| Education | $81.88 | 16 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $850.80 | 59 | $0 (2024) |
| PFIZER INC. | $774.52 | 55 | $0 (2024) |
| Novo Nordisk Inc | $738.29 | 65 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $706.00 | 72 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $695.56 | 42 | $0 (2024) |
| Merck Sharp & Dohme LLC | $684.83 | 49 | $0 (2024) |
| ABBVIE INC. | $618.69 | 48 | $0 (2024) |
| GlaxoSmithKline, LLC. | $587.53 | 38 | $0 (2024) |
| Allergan, Inc. | $495.05 | 36 | $0 (2020) |
| Lilly USA, LLC | $456.12 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,299 | 79 | E.R. Squibb & Sons, L.L.C. ($225.94) |
| 2023 | $1,722 | 104 | GlaxoSmithKline, LLC. ($299.80) |
| 2022 | $1,619 | 113 | ABBVIE INC. ($191.11) |
| 2021 | $730.32 | 52 | AbbVie Inc. ($236.58) |
| 2020 | $256.92 | 18 | GlaxoSmithKline, LLC. ($42.83) |
| 2019 | $1,174 | 93 | AstraZeneca Pharmaceuticals LP ($229.06) |
| 2018 | $1,618 | 127 | AstraZeneca Pharmaceuticals LP ($305.46) |
| 2017 | $1,784 | 145 | Allergan Inc. ($334.24) |
All Payment Transactions
731 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Oncology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.56 | General |
| Category: Cardiovascular | ||||||
| 12/12/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 12/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $25.84 | General |
| Category: Cardiovascular | ||||||
| 10/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: PAIN | ||||||
| 10/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.87 | General |
| Category: Cardiovascular | ||||||
| 10/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Gastroenterology | ||||||
| 10/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.69 | General |
| 10/02/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: VACCINES | ||||||
| 10/02/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: VACCINE | ||||||
| 09/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.61 | General |
| Category: PSYCHIATRY | ||||||
| 09/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Obesity | ||||||
| 09/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.31 | General |
| 09/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.95 | General |
| Category: Cardiovascular | ||||||
| 09/06/2024 | Abbott Laboratories | ACCENT (Device) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Cardiac Rhythm Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 295 | 481 | $100,714 | $41,365 |
| 2022 | 9 | 375 | 589 | $116,385 | $47,861 |
| 2021 | 11 | 381 | 631 | $132,276 | $57,110 |
| 2020 | 11 | 448 | 640 | $117,668 | $42,454 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 126 | 308 | $64,372 | $24,028 | 37.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 91 | 91 | $25,025 | $11,442 | 45.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 14 | $4,466 | $2,216 | 49.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 24 | 24 | $2,928 | $1,819 | 62.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 19 | $2,698 | $1,122 | 41.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $1,225 | $736.25 | 60.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 136 | 323 | $67,507 | $26,077 | 38.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 88 | 88 | $24,200 | $11,356 | 46.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 40 | 40 | $4,880 | $2,810 | 57.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 14 | 16 | $5,104 | $2,592 | 50.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 46 | $6,578 | $2,580 | 39.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 40 | 41 | $2,009 | $1,160 | 57.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $1,704 | $531.06 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,864 | $439.61 | 11.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $539.00 | $314.67 | 58.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 147 | 369 | $77,121 | $30,699 | 39.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 76 | 76 | $20,900 | $9,986 | 47.8% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 12 | 15 | $6,750 | $3,317 | 49.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 19 | 19 | $6,346 | $3,169 | 49.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 27 | 50 | $7,150 | $2,856 | 39.9% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 16 | 18 | $5,742 | $2,809 | 48.9% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 11 | 11 | $1,815 | $1,361 | 75.0% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 19 | 19 | $2,318 | $1,262 | 54.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 16 | $2,272 | $1,028 | 45.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 23 | $1,127 | $377.20 | 33.5% |
About Dr. Leonardo Amper, MD
Dr. Leonardo Amper, MD is a Internal Medicine healthcare provider based in Johnstown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346225869.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonardo Amper, MD has received a total of $10,204 in payments from pharmaceutical and medical device companies, with $1,299 received in 2024. These payments were reported across 731 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($10,122).
As a Medicare-enrolled provider, Amper has provided services to 1,499 Medicare beneficiaries, totaling 2,341 services with total Medicare billing of $188,790. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Johnstown, PA
- Active Since 12/07/2005
- Last Updated 12/02/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1346225869
Products in Payments
- ELIQUIS (Drug) $1,044
- XARELTO (Drug) $552.47
- FARXIGA (Drug) $496.98
- JANUVIA (Drug) $428.70
- INJECTAFER (Drug) $354.52
- TRELEGY ELLIPTA (Drug) $334.53
- UBRELVY (Drug) $334.37
- Vascepa (Drug) $277.42
- NAMZARIC (Drug) $235.89
- NURTEC ODT (Drug) $217.95
- QULIPTA (Drug) $217.09
- XIFAXAN (Drug) $204.40
- Ozempic (Drug) $200.21
- Kerendia (Drug) $178.72
- Prolia (Biological) $157.80
- INVOKANA (Drug) $153.53
- ZENPEP (Drug) $149.01
- SHINGRIX (Biological) $147.81
- TRULICITY (Drug) $147.64
- BRILINTA (Drug) $134.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Johnstown
Charles Oschwald, Md, MD
Internal Medicine — Payments: $159,339
Stephen Matse, Do, DO
Internal Medicine — Payments: $9,797
Dr. Shriram Sirsikar, M.d, M.D
Internal Medicine — Payments: $7,445
George Frem, Md, MD
Internal Medicine — Payments: $6,766
Dr. Balkissoon Maharajh, Md, MD
Internal Medicine — Payments: $6,020
Anwar Hussain, Md, MD
Internal Medicine — Payments: $4,458